Your browser does not support JavaScript! MOTION SICKNESS RELIEF (MECLIZINE HCL) TABLET, CHEWABLE [WALGREEN CO.]
DailyMed Logo Header image

Daily Med

Current Medication Information

Options

RxNorm Names

MOTION SICKNESS RELIEF (meclizine hcl) tablet, chewable
[WALGREEN CO.]


Category DEA Schedule Marketing Status
HUMAN OTC DRUG LABEL OTC monograph final
NOTE:MOST OTC DRUGS ARE NOT REVIEWED AND APPROVED BY FDA, HOWEVER THEY MAY BE MARKETED IF THEY COMPLY WITH APPLICABLE REGULATIONS AND POLICIES. FDA HAS NOT EVALUATED WHETHER THIS PRODUCT COMPLIES.
Drug Label Sections

Active ingredient (in each tablet)

Meclizine HCl 25 mg

Purpose

Antiemetic

Uses

  • prevents and treats nausea, vomiting, or dizzines associated with motion sickness 

Warnings

Do not use

for children under 12 years of age unless directed by a doctor

Ask a doctor before use if you have

  • glaucoma
  • difficulty in urination due to enlargement of the prostate gland
  • a breathing problem such as emphysema or chronic bronchitis 

Ask a doctor or pharmacist before use if you are

 taking sedatives or tranquilizers

When using this product

  • do not exceed recommended dosage
  • drowsiness may occur
  • avoid alcoholic drinks
  • alcohol, sedatives, and tranquilizers may increase drowsiness
  • be careul when driving a motor vehicle or operating machinery 

If pregnant or breast-feeding,

 ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

  • dosage should be taken one hour before travel starts
  • adults and children 12 years of age and over: take 1 to 2 tablets once daily or as directed by a doctor 

Other information

  • store at controlled room temperature 15º-30ºC (59º-86ºF)
  • protect from heat and humidity
  • for better identification keep talbets in carton until used
  • see end flap for expiration date and lot number 

Inactive ingredients

 corn starch, FD&C red #40 aluminum lake, lactose, magnesium stearate, rasberry flavor, silica gel, sodium saccharin

Questions or comments?

 1-800-426-9391

Principal Display Panel

NDC 0363-0404-21

Well at Walgreens
WALGREENS PHARMACIST RECOMMENDED†

LESS DROWSY FORMULA
Motion Sickness Relief
Meclizine HCl Tablets, 25 mg
Antiemetic
• Prevents motion sickness
• Chewable once-a-day protection

Compare to Bonine® active ingredient††

†Walgreens Pharmacist Survey Study, November 2010.
††This product is not manufactured or distributed by Insight Pharmaceuticals, owner of the registered trademark Bonine® Chewable Tablets.
50844    ORG011240421

Distributed by: Walgreen Co.,
200 Wilmot Rd., Deerfield, IL 60015-4616

TAMPER EVIDENT: DO NOT USE IF THE CARTON IS OPENED OR IF BLISTER UNIT IS TORN, BROKEN OR SHOWS ANY SIGNS OF TAMPERING

Walgreens 44-404

Walgreens 44-404

MOTION SICKNESS RELIEF 
meclizine hcl tablet, chewable
Product Information
Product TypeHUMAN OTC DRUG LABELItem Code (Source)NDC:0363-0404
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MECLIZINE HYDROCHLORIDE (MECLIZINE) MECLIZINE HYDROCHLORIDE25 mg
Inactive Ingredients
Ingredient NameStrength
FD&C RED NO. 40 
LACTOSE 
MAGNESIUM STEARATE 
Product Characteristics
ColorPINKScoreno score
ShapeROUNDSize10mm
FlavorRASPBERRYImprint Code 44;404
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0363-0404-211 in 1 CARTON
116 in 1 BLISTER PACK
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH FINALpart33605/29/2002
Labeler - WALGREEN CO. (008965063)
Establishment
NameAddressID/FEIBusiness Operations
LNK International, Inc.038154464PACK(0363-0404)
Establishment
NameAddressID/FEIBusiness Operations
LNK International, Inc.832867894MANUFACTURE(0363-0404)

Revised: 12/2012
 
WALGREEN CO.

Visit The National Library of Medicine Copyright, Privacy, Accessibility
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services